| B02BD02 |
Coagulation factor VIII (Moroctocog alfa) |
ReFacto AF |
Powder and solvent for solution for injection |
1000 |
IU |
1 |
Pfizer Limited, Обединено Кралство |
500 |
U |
1340.68 |
670.34003 |
1340.68 |
100% |
|
Съгласно РУ |
№ 180/ 27.07.2011.; КЦРР-1462/02.10.2012.; КЦРР-2039/21.01.2013; КЦРР-2536/14.03.2013. |
04.04.2013 |
08.09.2012 |
Заличен |
1648 |
| B02BD02 |
Coagulation factor VIII (Moroctocog alfa) |
ReFacto AF |
Powder and solvent for solution for injection |
250 |
IU |
1 |
Pfizer Limited, Обединено Кралство |
500 |
U |
348.11 |
674.82501 |
337.41 |
100% |
|
Съгласно РУ |
№ 180/ 27.07.2011.; КЦРР-1462/02.10.2012; НСР-3155/26.03.2014 |
16.04.2014 |
08.09.2012 |
Заличен |
1013 |
| B02BD03 |
coagulation factor, Factor VIII inhibitor bypassing activity |
B02BD03 coagulation factor, Factor VIII inhibitor bypassing activity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| B02BD03 |
factor VIII inhibitor bypassyng activity |
Feiba NF |
Powder and solvent for solution for injection |
500 U |
|
1 pre-filled syringe + powd.vial + solv.vial 20 ml + adm.set |
Baxter AG, Австрия |
10000 |
IU |
770.88 |
15417.59961 |
770.88 |
100% |
|
Съгласно РУ |
№ 190/ 22.08.2011; НСР-2195/20.12.2013 |
16.02.2014 |
08.09.2012 |
Активен |
2439 |
| B02BD04 |
Coagulation factor IX |
B02BD04 Coagulation factor IX |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| B02BD04 |
Coagulation factor IX |
Aimafix DI |
Powder and solvent for solution for infusion |
500 |
IU |
1 |
Kedrion S.p.A., Италия |
350 |
IU |
316.18 |
221.1049 |
316.18 |
100% |
|
Съгласно РУ |
№ 164/ 20.04.2011 |
|
08.09.2012 |
Активен |
369 |
| B02BD04 |
Coagulation factor IX |
IMMUNINE |
Powder and solvent for solution for injection/infusion |
600 |
IU |
1 |
Baxalta Innovations GmbH, Австрия |
350 |
IU |
486.84 |
221.1049 |
378.09 |
100% |
|
Съгласно РУ |
№ 190/ 22.08.2011; НСР-2198/20.12.2013; НСР-3381/29.04.2014 |
02.06.2014 |
08.09.2012 |
Активен |
2442 |
| B02BD04 |
Coagulation factor IX |
OCTANINE F 1000 |
Powder and solvent for solution for injection |
1000 |
IU |
1 |
Octapharma (IP) Ltd., Обединено Кралство |
350 |
IU |
799.54 |
221.1049 |
632.36 |
100% |
|
Съгласно РУ |
№ 162/ 20.04.2011; НСР-7583/26.11.2015. и КП-10/28.01.2016. |
02.03.2016 |
08.09.2012 |
Активен |
766 |
| B02BD04 |
Coagulation factor IX |
OCTANINE F 500 |
Powder and solvent for solution for injection |
500 |
IU |
1 |
Octapharma (IP) Ltd., Обединено Кралство |
350 |
IU |
405.78 |
221.1049 |
316.18 |
100% |
|
Съгласно РУ |
№ 162/ 20.04.2011; КП-26/15.02.2016 и НСР-7510/19.11.2015 |
02.04.2016 |
08.09.2012 |
Активен |
765 |
| B02BD06 |
Coagulation factor VIII, Factor von Willebrand |
B02BD06 Coagulation factor VIII, Factor von Willebrand |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| B02BD06 |
Coagulation factor VIII, Factor von Willebrand |
Wilate 1000 |
Powder and solvent for solution for injection |
1000 |
IU |
1 |
Octapharma (IP) Ltd., Обединено Кралство |
7200 |
IU |
938.96 |
6760.51221 |
938.96 |
100% |
|
Съгласно РУ |
НСР-1794/25.11.2013; НСР-5155/27.11.2014; НСР-6059/16.04.2015. |
16.05.2015 |
|
Заличен |
3419 |
| B02BD06 |
Coagulation factor VIII, Factor von Willebrand |
WILATE 450 powder for solution for injection 450 IU x 1 |
Powder and solvent for solution for injection |
450 |
IU |
1 |
Octapharma (IP) Ltd., Обединено Кралство |
7200 |
IU |
962.53 |
6845.75977 |
427.86 |
100% |
|
Съгласно РУ |
№ 162/ 20.04.2011; НСР-3931/30.06.2014 |
02.08.2014 |
08.09.2012 |
Заличен |
723 |
| B02BD06 |
Coagulation factor VIII, Factor von Willebrand |
Wilate 500 |
Powder and solvent for solution for injection |
500 |
IU |
1 |
Octapharma (IP) Ltd., Обединено Кралство |
7200 |
IU |
471.14 |
6730.57143 |
471.14 |
100% |
|
Съгласно РУ |
НСР-1794/25.11.2013; НСР-5154/27.11.2014; КП-394/06.11.2015 и НСР-7055/03.09.2015; НСР-10295/15.09.2016 |
02.11.2016 |
|
Активен |
3418 |
| B02BD06 |
Coagulation factor VIII, Factor von Willebrand |
WILATE 900 powder for solution for injection 900 IU x 1 |
Powder and solvent for solution for injection |
900 |
IU |
1 |
Octapharma (IP) Ltd., Обединено Кралство |
7200 |
IU |
856.92 |
6845.75977 |
855.72 |
100% |
|
Съгласно РУ |
№ 162/ 20.04.2011; КЦРР-2256/11.02.2013 и КП-4/05.02.2014; НСР-3931/30.06.2014 |
02.08.2014 |
08.09.2012 |
Заличен |
2556 |
| B02BD08 |
Eptacog alfa (activated) |
B02BD08 Eptacog alfa (activated) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| B02BD08 |
Eptacog alfa (activated) |
NovoSeven |
Powder and solvent for solution for injection |
2 mg (100KIU) |
|
1 vial + 1 vial |
Novo Nordisk A/S, Дания |
2500 |
TIU |
2590.99 |
64774.75 |
2590.99 |
100% |
|
Съгласно РУ |
№ 179/ 22.06.2011; КЦРР-1385/05.09.2012 г.; НСР-515/11.07.2013; НСР-3328/24.04.20124.; НСР-7854/15.01.2016. |
02.03.2016 |
08.09.2012 |
Активен |
2734 |
| B02BD08 |
Eptacog alfa (activated) |
NovoSeven |
Powder and solvent for solution for injection |
2 mg (100 KIU) |
|
1 vial + 1 syringe + 1 vial adapter |
Novo Nordisk A/S, Дания |
2500 |
KIU |
2590.99 |
64774.75 |
2590.99 |
100% |
|
Съгласно РУ |
НСР-11317/30.12.2016 |
02.02.2017 |
|
Активен |
15557 |
| B02BD08 |
Eptacog alfa (activated) |
NovoSeven |
Powder and solvent for solution for injection |
5 mg (250 KIU) |
|
1 vial + 1 syringe + 1 vial adapter |
Novo Nordisk A/S, Дания |
2500 |
KIU |
6793.08 |
64774.75 |
6477.48 |
100% |
|
Съгласно РУ |
НСР-11317/30.12.2016 г. |
02.02.2017 |
|
Активен |
15558 |
| B02BD08 |
Eptacog alfa (activated) |
NovoSeven 2.4 mg |
Powder and solvent for solution for injection |
120 |
KIU |
1 |
Novo Nordisk A/S, Дания |
2500 |
TIU |
3007 |
62645.83203 |
3007 |
100% |
|
Съгласно РУ |
КЦРР-982/16.07.2012 |
14.08.2012 |
08.09.2012 |
Заличен |
676 |
| B02BD09 |
nonacog alfa |
B02BD09 nonacog alfa |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| B02BD09 |
Nonacog alfa |
BeneFIX |
Solution for injection |
500 |
IU |
1 |
Pfizer Limited, Обединено Кралство |
450 |
IU |
684.13 |
615.717 |
684.13 |
100% |
|
Съгласно РУ |
HCР-19/31.05.2013 г. |
02.06.2013 |
|
Активен |
1849 |
| B02BX04 |
Romiplostim |
B02BX04 Romiplostim |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| B02BX04 |
Romiplostim |
NPLATE |
Powder and solvent for solution for injection |
250 |
mcg |
1 |
Amgen Eurоpe B.V., Нидерландия |
30 |
mcg |
1213.97 |
145.73469 |
1213.97 |
100% |
|
Съгласно РУ |
КЦРР-961/16.07.2012 г.; НСР-238/24.06.2013; НСР-4595/15.09.2014; НСР-7364/05.11.2015; НСР-9630/23.06.2016 |
02.08.2016 |
08.09.2012 |
Активен |
3204 |
| B02BX04 |
Romiplostim |
NPLATE |
Powder for solution for injection |
250 |
mcg |
1 |
Amgen Eurоpe B.V., Нидерландия |
30 |
mcg |
1258.84 |
151.06081 |
1258.84 |
100% |
|
Съгласно РУ |
48/ 09.02.2010; КЦРР-2113/28.01.2013 г.; КЦРР-2474/27.02.2013 г.; НСР-2774/17.02.2014 |
16.03.2014 |
08.09.2012 |
Заличен |
1693 |
| B02BX04 |
Romiplostim |
NPLATE |
Powder for solution for injection |
500 |
mcg |
1 |
Amgen Eurоpe B.V., Нидерландия |
30 |
mcg |
2922.28 |
151.8817 |
2531.87 |
100% |
|
Съгласно РУ |
48/ 09.02.2010; КЦРР-1452/02.10.2012 г. |
09.11.2012 |
08.09.2012 |
Заличен |
775 |